Integrated Core Strategies (US) LLC 13D/13G Filings for Aytu BioPharma, Inc. (AYTU)

Integrated Core Strategies (US) LLC 13D and 13G filings for Aytu BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-03-26
4:21 pm
Purchase
2021-03-1813GAytu BioPharma, Inc.
AYTU
Integrated Core Strategies (US) LLC457,320
0.100%
457,320increase
(New Position)
Filing